The Female Condom as HIV Prevention

The Female Condom

There remain a number of implementation and research questions around design, rollout, and uptake of the female condom.  R&D work in this area includes product developmentefforts, as well as basic HIV research, clinical trial preparation, community education, and advocacy—all of which are being funded by both the public and philanthropic sectors. Global investment in R&D related to the female condom totaled US$3.1 million in 2010 coming from the Female Condom Company, the Hewlett Foundation, the Universal Access to Female Condom (UAFC) Joint Programme and the NIH, The UAFC Joint Programme is a partnership among four Dutch organizations: Oxfam Novib, World Population Foundation, i+solutions, and the Dutch Ministry of Foreign Affairs.

47

HIV Vaccines and Microbicides Resource Tracking Working Group

All Content © 2000 - 2012 HIV Resource Tracking. Website Maintained by Progress Technology, Inc.
Log In / Administration